CVA Family Office’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-12
Closed -$431 1304
2024
Q3
$431 Buy
+12
New +$431 ﹤0.01% 1241